MedTrace Logo

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

NCT06139458 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2026-02-04

No results posted yet for this study

Summary

The investigators aim to determine the effect of cryotherapy wraps plus compression therapy (henceforth referred to as cryocompression) versus cryotherapy wraps alone on the incidence and degree of chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer using a noninferiority design. The investigators also aim to determine the effect of cryocompression versus cryotherapy on patient tolerability and patient and staff satisfaction.

Conditions

  • Gynecologic Cancer
  • Chemotherapy-induced Peripheral Neuropathy

Interventions

BEHAVIORAL

Cryotherapy

Participants will receive cryotherapy on both hands and feet

BEHAVIORAL

Compression

Participants will receive compression on both hands and feet

Sponsors & Collaborators

Principal Investigators

  • Laura Havrilesky · DUHS

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-18
Primary Completion
2027-01-31
Completion
2027-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06139458 on ClinicalTrials.gov